You are invited to submit a grant proposal to address the educational need outlined in the attached document.
Please review and return your completed proposal via the sanofi U.S. Grant Website at https://sgrants.envisionpharma.com/vt_sgrants/ by 5p.m. EST on Wednesday, June 14, 2017.
If a submission is not completed by this date, your proposal will not be accepted.
When entering proposal into the website, please reference the following:
Therapeutic Area: Immunology
Area of Interest: Rheumatoid Arthritis
RFP Name: Glbl RA RFP – Gnrl – 6/17
“Please note that an applicant may be ineligible to receive a grant in response to this RFP if the applicant has performed any services under contract with
sanofi U.S. during the last 12 months in connection with:
- A consultant meeting; or
- An advisory board meeting
in the same therapeutic area as this request for proposal (“RFP”).
If the applicant has performed such services, please forward a copy of the contract immediately, prior to responding to the RFP, so that we can determine your
eligibility. If not, please acknowledge this in your application writing.”
Please note that you must select the type of activity that you are proposing, i.e., Live, Enduring or Live and Enduring and answer the question, “Are you responding to an RFP” and Please select “Glbl RA RFP – Gnrl – 6/17 “ from the RFP
dropdown panel within the grant portal upon submitting your applicant for this RFP.
Submission instructions are available on the website. If you have a content question, please contact Malika Wicks at Malika.Wicks@sanofi.com.